phenyl acetate has been researched along with Osteoporosis in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (36.36) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Chu, J; Feng, B; Guo, W; Huang, C; Wei, J; Yang, S | 1 |
| Cui, L; Huang, J; Li, G; Li, N; Lin, S; Liu, G; Liu, Y; Qin, L; Wang, K; Wu, T; Zheng, L; Zou, L | 1 |
| MIZUSHIMA, T | 1 |
| KITTEL, K | 1 |
| POZZI, L; SALVI, V | 1 |
| Apter, AJ; Szefler, SJ | 1 |
| Barrett-Connor, EL; Morton, DJ; Schneider, DL | 1 |
| Adams, PC; Azzarano, LM; Bondinell, WE; Bradbeer, J; Cousins, RD; Drake, FH; Erhard, KF; Gowen, M; Haltiwanger, RC; Hoffman, SJ; Huffman, WF; Hwang, SM; Jakas, DR; James, IE; Keenan, RM; Ku, TW; Lark, MW; Lechowska, B; Miller, WH; Newlander, KA; Rieman, DJ; Ross, ST; Stroup, GB; Vasko-Moser, JA; Zembryki, DL | 1 |
| Bradbeer, JN; Drake, FH; Erhard, KF; Gowen, M; Huffman, WF; Hwang, SM; James, IE; Lark, MW; Mathur, A; Miller, WH; Newlander, KA; Rieman, DJ; Ross, ST; Salyers, KL; Smith, BR; Stroup, GB | 1 |
| Heicappell, R; Miller, K; Müller, M; Schrader, M; Straub, B | 1 |
| Little, K | 1 |
2 review(s) available for phenyl acetate and Osteoporosis
| Article | Year |
|---|---|
[THE ANABOLIC STEROID 4-CHLOROTESTOSTERONE 17-BETA-ACETATE].
Topics: Acetates; Anabolic Agents; Drug Therapy; Heart Diseases; Hyperthyroidism; Kidney Diseases; Liver Diseases; Osteoporosis; Pharmacology; Research; Steroids; Toxicology | 1964 |
Advances in adult and pediatric asthma.
Topics: Acetates; ADAM Proteins; Administration, Inhalation; Adrenal Cortex Hormones; Adult; Anti-Asthmatic Agents; Asthma; Child; Cyclopropanes; Female; Humans; Male; Metalloendopeptidases; Osteoporosis; Pregnancy; Pregnancy Complications; Quinolines; Respiratory System; Sulfides; United States | 2004 |
1 trial(s) available for phenyl acetate and Osteoporosis
| Article | Year |
|---|---|
Nonsteroidal anti-inflammatory drugs and bone mineral density in older women: the Rancho Bernardo study.
Topics: Absorptiometry, Photon; Acetates; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Bone Density; Cohort Studies; Collagen; Collagen Type I; Community Health Services; Female; Humans; Middle Aged; Osteoporosis; Peptides; Propionates | 1998 |
8 other study(ies) available for phenyl acetate and Osteoporosis
| Article | Year |
|---|---|
Leukotriene D4 induces cellular senescence in osteoblasts.
Topics: Acetates; Animals; beta-Galactosidase; Cell Line; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p21; Cyclopropanes; Humans; Leukotriene D4; Mice; Osteoblasts; Osteoporosis; Plasminogen Activator Inhibitor 1; Quinolines; Receptors, Leukotriene; RNA, Small Interfering; Sirtuin 1; Sulfides; Tumor Suppressor Protein p53 | 2018 |
Glucocorticoid-induced osteoporosis in growing rats.
Topics: Acetates; Animals; Biomarkers; Biomechanical Phenomena; Body Weight; Bone Resorption; Densitometry; Disease Models, Animal; Dose-Response Relationship, Drug; Fluoresceins; Glucocorticoids; Male; Osteoporosis; Prednisone; Principal Component Analysis; Rats; Rats, Sprague-Dawley; Stress, Mechanical; Tetracycline; Time Factors; X-Ray Microtomography | 2014 |
[EXPERIMENTAL OSTEOPOROSIS (1)].
Topics: Acetates; Adrenalectomy; Castration; Citrates; Cortisone; Desoxycorticosterone; Estradiol Congeners; Estrogens; Female; Humans; Male; Orchiectomy; Osteoporosis; Ovary; Pharmacology; Rats; Research; Testis | 1964 |
[Results of the clinical use of 4-chlortestosterone acetate in the treatment of dysendocrine osteoporosis].
Topics: Acetates; Osteoporosis; Testosterone | 1959 |
Orally bioavailable nonpeptide vitronectin receptor antagonists with efficacy in an osteoporosis model.
Topics: Acetates; Administration, Oral; Aminopyridines; Animals; Benzodiazepinones; Biological Availability; Disease Models, Animal; Kinetics; Osteoporosis; Rats; Receptors, Vitronectin; Time Factors | 1999 |
Design and characterization of orally active Arg-Gly-Asp peptidomimetic vitronectin receptor antagonist SB 265123 for prevention of bone loss in osteoporosis.
Topics: Acetates; Administration, Oral; Aminopyridines; Animals; Bone Resorption; Cell Adhesion; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Humans; In Vitro Techniques; Infusions, Intravenous; Integrins; Osteoporosis; Ovariectomy; Parathyroidectomy; Platelet Aggregation; Protein Binding; Rats; Receptors, Vitronectin; Thyroidectomy; Time Factors | 1999 |
Osteoporosis and mild metabolic acidosis in the rat after orchiectomy and their prevention: should prophylactic therapy be administered to patients with androgen deprivation?
Topics: Acetates; Acidosis; Androgens; Animals; Bone and Bones; Bone Density; Calcium; Calcium Compounds; Citrates; Femoral Fractures; Hydrogen-Ion Concentration; Intestinal Absorption; Magnesium; Male; Orchiectomy; Osteoporosis; Phosphorus; Rats; Rats, Sprague-Dawley; Sodium Citrate; Stress, Mechanical | 2001 |
Some mechanisms involved in the osteoporotic process.
Topics: Acetates; Aged; Animals; Autopsy; Bone and Bones; Bone Resorption; Cortisone; Female; Humans; Immobilization; Menopause; Middle Aged; Muscle Contraction; Osteoporosis; Rabbits | 1968 |